Novartis wins US court appeal after challenge to Gilenya pat

This decision confirms the validity of the Gilenya patent and allows that injunction to remain in place, Novartis said

Related Keywords

, Novartis , Wall Street , Gilenya Patent , Us Court , Multiple Sclerosis Drug , Hec Pharma ,